ServiceNow's NBA Win Lands in the Same Week Its Forward Book Gets Graded
SK Hynix's US Ambitions Run Into a Dalian Paper Jam
Progress Software stock draws fresh institutional interest from Prescott Group
Lexicon Pharmaceuticals stock faces Q3 results before market open
Lyell Immunopharma stock: financing supports ronde-cel BLA plan
Liberty Latin America stock enters focus after Q3 results release
Pyxis Oncology stock: CEO sets November healthcare conference talks
Martin Marietta stock: Q3 revenue jumps as margins tighten
Edison International stock: Q3 core EPS slips, guidance reaffirmed
Minera Frisco stock: Q2 revenue reaches MXN 6.45 billion
Eastman Chemical stock: RBC lifts price target to USD 70
Green Bridge Metals Posts Wider Losses as Titac North Drilling Gets Underway
Lenovo's Motorola Handover and AMD's Helios Signal Put Two Clocks on the Same Trade
NextCure stock draws additional buying from ADAR1 funds
Equifax stock faces lower 2026 EPS forecast from Zacks
Oracle's AI Ambitions Face a Reckoning: Can the Cloud Giant Turn Gigawatts Into Free Cash?
EHang stock expands emergency aviation lineup with new eVTOL
Kraft Heinz stock gets higher 2026 EPS outlook after Q3 results
Etsy stock: Q3 revenue rises 10.9% to USD 692.5 million
MiMedx Group stock: Surgical growth offsets steep Wound decline
Montauk Renewables stock heads into key third-quarter earnings test
Fastly stock posts record Q3 revenue and lifts 2026 outlook
Kemper stock: Q3 profit outlook leaves auto recovery unfinished
Prelude Therapeutics stock narrows focus to three cancer programs
The Joint stock heads into earnings release after market close
Onterris stock in focus after Q3 profit rises as revenue falls
Invivyd stock: Biotech grants options to new employees
Fate Therapeutics stock: New hires receive 300,000 options
Li-Metal stock follows proposed investment pivot after filing
Kandi Technologies stock completes 1-for-10 reverse split
1-800-FLOWERS.COM stock faces earnings test after softer quarter
NN stock: Company raises 2026 outlook after strong Q3
Inhibrx Biosciences stock faces a busy clinical-data calendar
Lennox stock faces lower outlook after third-quarter margin pressure
Rolls-Royce's Technical Wins Face a Customer's Verdict
Rheinmetall's Strong Quarter Meets a Softer Year as Arminius Slips